Director, Clinical Microbiology Laboratory, Associate Director, Division of Clinical Pathology, Professor of Pathology, University of Michigan
BIOGRAPHY
AUG 26, 2020 11:00 AM PDT | AUGUST 27, 11:00 AM SGT | AUGUST 27, 4:00 PM CEST
SARS-CoV-2 Quality Control for Molecular and Serology assays
Presented at:
A Bio-Rad Quality Control Virtual Conference
Speakers
-
Elitza S. Theel, PhD, D(ABMM)
Director, Infectious Diseases Serology Laboratory, Clinical Microbiology Division, Department of Laboratory Medicine and Pathology, the Mayo Clinic, MinnesotaBIOGRAPHY
Abstract
SARS-CoV-2 has created significant challenges for laboratories, requiring the development, validation, and scale up of testing in a very short time period--often this was done for multiple methods due to capacity demands and supply chain shortages. Part of assuring quality test results is the confidence in testing that comes from a robust QC Program. In this webinar, the speakers will discuss different issues to be considered for QC material selection, as well as QC program design & strategies for SARS-CoV-2 molecular and serology testing.
Learning Objectives:
1. Describe approaches to quality control for SARS-CoV-2 molecular testing that monitor the entire testing process
2. Discuss quality control approaches for high-throughput SARS-CoV-2 antibody tests
3. List 2 optimal QC practices for each methodology
Resources:
SARS-CoV-2 Quality Control for Molecular and Serology Assays Handout
Q&A Sessions SARS-CoV-2 Quality Control for Molecular and Serology Assays
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...